ABSTRACT This study examines the impact of ex ante litigation risk on auditor hiring and retention. Using employee data from LinkedIn, we find ex ante accounting-related litigation risk is associated with fewer auditors joining and more auditors leaving an audit office, whereas we fail to find any impact of nonaccounting litigation risk. Moreover, ex ante accounting-related litigation risk is associated with audit firms' hiring less experienced and less educated auditors, suggesting ex ante litigation risk impacts the quality of auditing hires. We also find that the impact of ex ante litigation risk is concentrated in audit offices with more outside job opportunities and in those that are more susceptible to changes in litigation risk. Our results highlight the impact of ex ante litigation risk on audit labor supply, providing insights concerning the unintended consequences of increasing auditors' legal liability. Data Availability: All data used in this study are based on publicly available information obtained through the services or authors cited in the manuscript. JEL Classifications: M42.

This paper studies voluntary disclosures that firms have suspended, resumed, or completed their open market repurchase programs. Voluntary disclosures of repurchase status updates are common and value‐relevant. They also inform subsequent repurchase activities: voluntary disclosers are more likely to complete their repurchase programs and to initiate new repurchase programs than firms with undisclosed repurchase status changes. Moreover, firms that disclose repurchase suspensions experience larger returns to subsequent repurchase authorizations, consistent with a reward for establishing a reputation for transparency via voluntary bad news disclosure. Finally, exploiting a change in repurchase reporting requirements, we document that voluntary updates are less frequent when mandatory disclosure increases. An important exception, however, is when macroeconomic uncertainty is high, such as during the Great Recession and the COVID‐19 pandemic.